June 10, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW ORLEANS — In patients with gestational diabetes who took insulin after a standardized breakfast meal, inhaled technosphere insulin was comparable to rapid-acting analog insulin, researchers reported. Amy M. Valent, DO, assistant professor of obstetrics and gynecology at Oregon Health and Science University, and colleagues conducted a study presented as a poster at the American Diabetes
June 10, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1

Triple hormone receptors, a monthly obesity drug, and a bittersweet ending

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Roche’s incretin shot works in mid-stage trial in type 1 diabetes

Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

Newer GLP-1s, pushback on research cuts, and a protest

Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

ADOCIA Announces THDB0206 (BioChaperone® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming the Positive Results Previously Announced in July 2025

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…

The FDA has approved technosphere insulin, an inhaled form of human insulin, for children and adolescents aged 6 years and older…

NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a…

NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with…

NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and…

WASHINGTON — GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to…